Indication

Anemia in beta thalassemia

Anemia in beta thalassemia is an inherited hematologic condition characterized by impaired oxygen-carrying capacity due to deficient or absent synthesis of the beta-globin chains of adult hemoglobin. Read more about Anemia in beta thalassemia

5 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Anemia in beta thalassemia therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Anemia in beta thalassemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anemia in beta thalassemia.

Anemia in beta thalassemia is an inherited hematologic condition characterized by impaired oxygen-carrying capacity due to deficient or absent synthesis of the beta-globin chains of adult hemoglobin.

Primarily affecting individuals of Mediterranean, Middle Eastern, Central and South Asian, and African ancestry, this quantitative hemoglobinopathy results in an excess of unbound alpha-globin chains that form unstable aggregates within developing and mature erythrocytes.

These intracellular precipitates drive hallmark pathophysiologic processes, including premature erythroid precursor destruction within the bone marrow—termed ineffective erythropoiesis—and peripheral hemolysis.

Consequently, patients develop microcytic, hypochromic anemia ranging clinically from mild, asymptomatic presentations to severe, life-threatening transfusion-dependent disease complicated by extramedullary hematopoiesis, splenomegaly, and systemic iron overload.

Personalize your experience

Follow Anemia in beta thalassemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it